BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
SciQuest's big get: a UNC system deal
-
The University of North Carolina General Administration Signs Systemwide Agreement with SciQuest
-
Utility, University to Build Offshore Wind Turbines
-
Governor Perdue Declares November 16-20 College Application Week; Students Across the State Set to Apply...
-
U North Carolina To Pilot Coastal Wind Turbine Project
-
University data breach exposes 163,000 women to identity theft
-
UNCW wins grant to fight violent crimes against women
-
N.Y.’s Albany County mandates menu labeling
-
Hardees and Tar Heels to Turn It Blue in Celebration of 100
News & Analysis
Filter by
patent and university of north carolina - All News and Analysis
University of North Carolina at Chapel Hill obtains United States patent.(asymmetric derivatives of furamidines)(Brief article)
University of North Carolina at Chapel Hill (Chapel Hill, NC) and Georgia State University Research Foundation, Inc. (Atlanta, GA) have patented asymmetric derivatives of furamidines with one of the phenyl rings of furamidine replaced with a benzimidazole, found by quantitative footprinting analyses to bind GC containing...
Wake Forest obtains United States patent.(Wake Forest University School of Medicine and University of North Carolina)(Brief article)
Wake Forest University School of Medicine (Winston-Salem, NC) and University of North Carolina at Chapel (Chapel Hill, NC) has patented compositions and methods useful for treatment of a virus infection in a mammal by double-targeting the virus (i.e. targeting the virus at more than one stage...
LeukoMed Inc
LeukoMed Inc. of Research Triangle Park announced recently that the European Patent Office granted Patent No. 0767793, titled "N-substituted- dihydroxyboryl alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines," to the University of North Carolina at Chapel Hill. LeukoMed is developing two lead drug candidates based on...
University of North Carolina obtains United States patent.(for DNA sequences encoding human androgen receptor protein)(Brief Article)
University of North Carolina at Chapel Hill (Chapel Hill , NC) has patented DNA sequences encoding human androgen receptor protein and polypeptides and proteins having substantially the same biological activity as human androgen receptor protein and the amino acid sequences of human androgen receptor protein and...
University of North Carolina obtains United States patent.(University of North Carolina patent forl entiviral vector expression)(Brief Article)
University of North Carolina (Chapel Hill, NC) has patented a recombinant lentiviral vector expression system which is a first vector that comprises a nucleic acid sequence of at least part of the Equine Infectious Anemia Virus genome. (US 6277633)
Australian patent granted to Xanthon and University of North Carolina.(Brief Article)
Xanthon, Inc. (Research Triangle Park, NC; 919-572-0707) announced that the Australian Patent Office has granted Patent 729118 entitled, "Electrochemical Probes for Detection of Molecular Interactions and Drug Discov-ery," jointly to Xanthon and the University of North Carolina at Chapel Hill (Chapel Hill, NC). Inventors named on...
Incara announces issuance of additional patent for isolating liver progenitor cells.(Brief Article)
Incara Pharmaceuticals Corporation (Research Triangle Park NC; 919-558-1907) announced the issuance from the United States Patent and Trademark Office of patent number 6,242,252 entitled "Hepatic progenitors and methods of isolating same." Hepatic progenitors, which include liver stem cells, are potentially capable of...
Xanthon announces issuance of nucleic acid hybridization detection patent.(Brief Article)
Xanthon Inc., (Research Triangle Park, NC), announced that the United States Patents and Trademarks Office has issued Patent Number 5,968,745 "Polymer-Electrodes for Detecting Nucleic Acid Hybridization and Method of Use Thereof" to Dr. Holden Thorp, Professor of Chemistry at the University of North Carolina (Chapel Hill,...
University of North Carolina applies for patent.(Brief Article)
University of North Carolina (Chapel Hill, NC) has applied for a patent covering a composition for modifying mammalian cells useful for stimulating immune response in cancer patients. (US Appl. 81092; WO Publication 9951263)
Intellectual Property: Investing In Good Ideas
By Richard Ray, News Services, the University of North Carolina atChapel HillA university researcher is trying to analyze the breakdown ofnucleotides when he stumbles upon the beginnings of a new DNAdetection technology that will be the basis for a new biotechnologycompany.This scenario sounds like the stuff of science fiction and...
- 1


